This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pfizer Inc (PFE)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 48.85B 49.60B 51.58B 58.99B
Cost of Sales 9.65B 8.08B 7.78B 8.90B
Gross Operating Profit 39.20B 41.53B 43.81B 50.09B
Selling, General, and Administrative Expenses 14.81B 14.10B 14.36B 16.62B
Research & Development 7.69B 8.39B 6.68B 7.87B
Operating Income before D & A (EBITDA) 16.70B 19.04B 22.78B 25.60B
Depreciation & Amortization 3.73B 5.54B 6.41B 7.61B
Interest Income 471.00M 0.00 403.00M 383.00M
Other Income - Net -2.50B 0.00 964.00M 0.00
Special Income / Charges n.a. -1.01B 579.00M -2.89B
Total Income Before Interest Expenses (EBIT) 10.95B 12.24B 17.13B 13.60B
Interest Expense 1.20B 0.00 1.41B 1.52B
Pre-Tax Income 9.75B 12.24B 15.72B 12.08B
Income Taxes 1.99B 3.12B 4.31B 2.56B
Minority Interest 26.00M 33.00M 69.00M 28.00M
Net Income From Continuing Operations 7.76B 9.12B 11.41B 9.52B
Net Income From Discontinued Operations 11.00M 48.00M 10.66B 5.08B
Net Income From Total Operations 7.77B 9.17B 22.07B 14.60B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 1.00M 0.00 0.00 0.00
Total Net Income 7.75B 9.13B 22.00B 14.57B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 10.38B 12.01B 14.29B
Preferred Dividends
Net Income Available To Common 0.00 9.12B 11.41B 9.52B
Basic EPS from Continuing Ops. 1.25 1.43 1.67 1.27
Basic EPS from Discontinued Ops. 0.00 0.01 1.56 0.68
Basic EPS from Total Operations 1.25 1.44 3.23 1.95
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.01
Basic EPS, Total 1.25 1.44 3.23 1.96
Basic Normalized Net Income/Share n.a. 1.63 1.76 1.91
EPS fr Continuing Ops. 1.24 1.41 1.65 1.26
EPS fr Discontinued Ops 0.00 0.01 1.54 0.68
EPS fr Total Ops. 1.24 1.42 3.19 1.94
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.24 1.42 3.19 1.94
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 1.60 1.74 1.89
Dividends Paid per Share 1.12 1.04 0.96 0.88
PFE News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for PFE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 8 8 8 8
Moderate Buy 0 1 1 1
Hold 3 3 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
GET PFE ANALYST REPORT

PFE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs